Press Release
For more information, visit: http://www.interscience.wiley.com/journal/arthritis
Amy Molnar
(201) 748-8844/8852 (fax)
E-mail:
For Immediate Release:
January 7, 2005
Arthritis & Rheumatism News Alert
A Biomarker To Predict Osteoarthritis
Study of large, ethnically diverse population shows strong association between
high levels of hyaluronic acid and severe osteoarthritis of the knees and hips
A chronic degenerative joint disease, osteoarthritis (OA) is a common cause
of pain and disability among older Americans. OA of the knee affects up to
6 percent of the older population, while OA of the hip affects about another
3 percent. While treatments vary, there is hope that early intervention – before
joint destruction can be clearly seen and measured on an X-ray image-will improve
outcomes.
The need for better ways to assess OA's activity from its onset has led researchers
to investigate possible biomarkers, particularly those related to cartilage
and bone turnover. A biomarker is substance found in the blood or joint fluid
whose levels can be used to assess the presence or activity of a disease. Among
likely candidates for a biomarker for OA is hyaluronic acid, also known as
hyaluronan or simply HA. HA is a component of connective tissue that is widely
distributed throughout the body and plays an important role in joint function.
A recent study, published in the January 2005 issue of Arthritis & Rheumatism ( http://www.interscience.wiley.com/journal/arthritis),
strongly supports the relationship between increased production of HA and increased
risk for OA, specifically of the knees and hips, among ethnically diverse men
and women.
Led by Drs. Alan L. Elliott and Joanne M. Jordan of the Thurston Arthritis
Research Center, University of North Carolina at Chapel Hill, and Dr. Virginia
B. Kraus of Duke University Medical Center, the study drew its subjects from
a large, local population of participants in the Johnston County Osteoarthritis
Project. The study group comprised 753 subjects, including 120 African American
men, 245 African American women, 199 Caucasian men, and 189 Caucasian women.
The average age of the participants was just shy of 62 years and the mean body
mass index was on the heavy side, just over 30. Of the total subjects, 455
had mild to severe knee OA, confirmed by radiographs. 152 of the subjects with
knee OA also had hip OA. In 52 of these individuals with OA, the disease had
progressed to both knees and both hips.
The research team obtained a blood sample from every participant and analyzed
each for its concentration of HA. Across the board, Caucasians had higher serum
HA levels than African Americans and men had higher serum HA levels than women.
The most compelling differences in HA levels, however, were between the 298
subjects without any radiographic evidence of OA and the 455 OA participants – especially
those with two or more joints affected. As the presence and amount of OA involvement
increased, so did the HA levels. On average, the concentration of HA was higher
in patients with severe knee OA compared to those in the moderate stages of
disease, higher in patients with two diseased knees compared to those with
a single diseased knee, and higher in patients with hip OA in addition to knee
OA compared to those with knee OA alone. When adjusted for ethnicity, sex,
age, and BMI, the associations between elevated HA levels and all definitions
of OA status remained statistically significant.
Also significantly, researchers found no independent correlations between
elevated levels of HA and other adverse health conditions reported by the subjects,
including high blood pressure, diabetes, chronic pulmonary disease, persistent
liver, kidney, bladder, and prostate problems, and cancer. Only one condition
showed a sustained independent relationship with elevated HA after statistical
adjustment: gout, which, like OA, is marked by joint inflammation and damage.
“The results of this study suggest that serum HA measurements are useful for
assessing overall OA load,” Dr Elliott notes. “The lack of independent associations
of serum HA levels with several comorbid conditions commonly associated with
OA further supports its promise in the study of OA.”
Article : “Serum Hyaluronan Levels and Radiographic Knee
and Hip Osteoarthritis in African Americans and Caucasians in the Johnston
County Osteoarthritis Project,” Alan L. Elliott, Virginia B. Kraus, Gheorghe
Luta, Thomas Stabler, Jordan B. Renner, Janice Woodard, Anca D. Dragomir, Charles
G. Helmick, Marc C. Hochberg, and Joanne M. Jordan, Arthritis & Rheumatism ,
January 2005; 52:1; pp. 105-111.